Status | Study |
Completed |
Study Name: Behavior Change on Oral Cancer Patients After a Localized Behavior Change Model Intervention Condition: Oral Cancer Date: 2011-05-09 Interventions: Behavioral: smoking cessation program |
Completed |
Study Name: Polarized Reflectance Spectroscopy for Oral Lesions Condition: Oral Cancer Date: 2010-11-03 Interventions: Device: Polarized Reflectance Spectroscopy System Fiber optic probe designed to measure polarized reflec |
Active, not recruiting |
Study Name: PET/CT and Sentinel Node in Oral Cancer Condition: Oral Cancer Date: 2010-06-02 |
Completed |
Study Name: Study to Assess Biomarkers in Patients With Resectable Oral Cavity Cancer Randomized to Receive Preoperative Treatment Condition: Oral Cavity Cancer Date: 2010-05-03 Interventions: Drug: PF-00299804 PF-00299804 or Placebo given pre-operatively for 7 to 11 days depending on surgery sch |
Completed |
Study Name: Epstein-Barr Detection in Oral Cancer Condition: Oral Cancer Date: 2009-12-22 |
Recruiting |
Study Name: Efficacy of Optically-guided Surgery in the Management of Early-staged Oral Cancer - COOLS TRIAL Condition: Oral Cancer High-grade Precancer Date: 2009-12-22 Interventions: Procedure: Fluorescence visualization device |
Terminated |
Study Name: A Study of High-Risk Oral Cavity Cancer Condition: Oral Cavity Cancer Date: 2009-07-07 Interventions: Drug: Thalidomide, Celebrex Im |
Completed |
Study Name: Workplace Tobacco Cessation And Oral Cancer Screening Study Condition: Tobacco Cessation Oral Cancer Date: 2008-09-09 Interventions: Behavioral: Behavioural and Pharmacotherapy for tobacco cessation Professional help in the form of healt |
Completed |
Study Name: Oral Cancer Screening in Mumbai, India by Primary Health Care Workers Condition: Oral Cancer Precancerous Conditions Date: 2008-04-03 Interventions: Other: Unaided Visual Inspection |
Active, not recruiting |
Study Name: Erlotinib Prevention of Oral Cancer (EPOC) Condition: Oral Cancer Date: 2006-11-20 Interventions: Drug: Erlotinib 150 mg by mout |